Captor Therapeutics Spolka Akcyjna
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CTX.WA research report →
About the company
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor.
- CEO
- Michal Jerzy Walczak
- IPO
- 2021
- Employees
- 91
- HQ
- Wroclaw, SL, PL
Price Chart
- Market Cap
- $481.97M
- P/E
- -9.86
- P/S
- 202.34
- P/B
- 35.02
- EV/EBITDA
- -11.87
- Div Yield
- 0.00%
- Gross Margin
- 3.44%
- Op Margin
- -1973.80%
- Net Margin
- -1790.64%
- ROE
- -150.18%
- ROIC
- -306.09%
- Revenue
- $4.66M · -70.55%
- Net Income
- $-41,997,000 · -9.29%
- EPS
- $-7.61 · 7.76%
- Op Income
- $-53,207,000
- FCF YoY
- -13.93%
- 52W High
- $89.20
- 52W Low
- $31.50
- 50D MA
- $78.52
- 200D MA
- $67.51
- Beta
- 0.65
- Avg Volume
- 3.36K
Get TickerSpark's AI analysis on CTX.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CTX.WA coverage
Recent articles, reports, and earnings notes.
No research on CTX.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CTX.WA report →Similar companies
Peers in the same neighborhood.